<DOC>
	<DOC>NCT01471886</DOC>
	<brief_summary>The purpose of this study is to evaluate the non-inferiority of the clinical efficacy of two different drugs in the treatment of patients diagnosed with moderate to severe back pain.</brief_summary>
	<brief_title>Comparison Of Ketorolac Tromethamine Versus Naproxen For Moderate to Severe Back Pain Treatment</brief_title>
	<detailed_description>- double-blind, double-dummy, non-inferiority, prospective, parallel group, intent to treat trial. - Experiment duration: 04 days. - 03 visits (days 0, 2 and 4). - Efficacy will be evaluated for back pain relief based on visual analog scale. - Adverse events evaluation.</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Consent of the patient or legal guardian. Men or women aged between 18 and 65. Diagnosis of acute low back pain with moderate to severe pain (Visual Analog Scale greater than 4 cm) fracture confirmed by Xray Diagnosis of infection, fever, Pregnancy, lactation; Diagnosis of fibromyalgia; Hypersensitivity to ketorolac tromethamine, any of the ingredients of the formula or other Nonsteroidal antiinflammatory</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>